Thinking up tomorrow's medicine
On October 3rd this year, this seminar, co-organized with Merck Millipore and Biopractis, brought together about forty people at the Nantes University Health Research Institute (IRS-Un). Companies, researchers and project leaders were able to become aware of the crucial stages in the development of biomolecules.
Initiated in 2010, European Interreg project comprises 5 clusters and combines 250 SMEs specializing in biomaterials. The objective is to set up a support network for innovation in the field of "Biomaterials" in Northwest Europe (NWE area). Spread over 46 months, the project has already enabled the implementation of tools and other concrete results.
The next meeting entitled “What's Up”, which will be organized with the Media & Networks cluster in Nantes, will showcase new technologies which are at the service of personalized medicine. Technologies such as how to store and use large volumes of scientific and medical data, how to remotely monitor patients and what systems are already experienced? This event will be an opportunity to develop new collaborations at the interface between Health and ICT.
This two-day international workshop features presenta¬tions by leading actors in the field of anti-tumor immunity from academia, industry and biotech companies providing a platform for scientific discussion and launching of colla-borative projects.
The Atlanpole Biotherapies competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation.
Our ambition is to become a reference center on an international scale for the development of diagnostic and therapeutic solutions in the field of biotherapies.
Atlanpole Biotherapies is a competitive cluster certified by the Ministry of Industry (July 2005).